StoriesSourcesLog inSign up

PERSPECTA

News from every angle

TrendingCorporate Earnings & InvestmentStock Market & InvestingGlobal Economic Indicators and Market TrendsStock Market & Tech InvestmentsCorporate Earnings & Business Outlook
HotByteDance Curbs AI Video App After Disney Copyrigh...12Winter Olympics 2026: Daily Highlights and Key Mom...11Ukraine War Reaches Critical Juncture Amidst Diplo...11Winter Olympics 2026 Sees GB Gold, Italian Success...9US and Iran Continue Nuclear Program Talks in Gene...7
← Back to headlines

Phathom Pharmaceuticals Shifts Focus to GI, Aims for Profitability by 2026

Phathom Pharmaceuticals announced a strategic pivot towards gastrointestinal focus and targets profitability by the second half of 2026, as revealed by its CEO at the Guggenheim Summit.

14 Feb, 22:05 — 14 Feb, 22:05

How outlets covered this

Yahoo

Phathom Pharmaceuticals Pivots to GI Focus, Targets 2H 2026 Profitability, CEO Says at Guggenheim Summit

yahoo-finance

Phathom Pharmaceuticals Pivots to GI Focus, Targets 2H 2026 Profitability, CEO Says at Guggenheim Summit

Coverage (2 sources)

Yahoo14 Feb, 22:05

Phathom Pharmaceuticals Pivots to GI Focus, Targets 2H 2026 Profitability, CEO Says at Guggenheim Summit

Read at source →
yahoo-finance14 Feb, 22:05

Phathom Pharmaceuticals Pivots to GI Focus, Targets 2H 2026 Profitability, CEO Says at Guggenheim Summit

Read at source →